Related Experiment Video
Updated: Jun 28, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells
Ankit Srivastava1, Shruti Mishra1, Avadhesh1
1Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221 005, India.
Abstract:
Prohibitin (PHB) is a pleiotropic molecule with a variety of known functions and subcellular locations. PHB's function in breast cancer is poorly understood. Herein, we report that PHB is expressed in cancer types of diverse origin including breast cancer. The cancer patients with changes in PHB were reported to have significantly reduced 'overall survival' in comparison to the cases without alterations in PHB. The expression of PHB was increased by H2O2 and also by Moringin (MG), which is an isothiocyanate derived from the seeds of Moringa oleifera. MG interacted with PHB, DRP1, and SLP2 and inhibited the growth of MCF-7 and MDAMB-231 cells. The isothiocyanate triggered apoptosis in breast cancer cells as revealed by AO/PI assay, phosphatidylserine externalization, cell cycle analysis and DAPI staining. MG induced proapoptotic proteins expression such as cytochrome c, p53, and cleaved caspase-7. Further, cell survival proteins such as survivin, Bcl-2, and Bcl-xL were suppressed. A depolarization of membrane potential suggested that the apoptosis was triggered through mitochondria. The isothiocyanate suppressed the cancer cell migration and interacted with NF-κB subunits. MG suppressed p65 nuclear translocation induced by TNF-α. The reactive oxygen species generation was also induced by the isothiocyanate in breast cancer cells. MG also modulated the expression of lncRNAs. Collectively, the functions of PHB in breast cancer growth is evident from this study. The activities of MG against breast cancer might result from its ability to modulate multiple cancer-related targets.
Insights
Prohibitin (PHB) expression impacts breast cancer survival. Moringin (MG), a natural compound, inhibits cancer cell growth by inducing apoptosis and suppressing key survival proteins, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prohibitin (PHB) is a pleiotropic molecule with poorly understood roles in breast cancer.
- PHB expression is altered in various cancers, correlating with reduced overall survival.
Purpose of the Study:
- To investigate the role of PHB in breast cancer.
- To evaluate the anti-cancer effects of Moringin (MG), an isothiocyanate from Moringa oleifera seeds.
Main Methods:
- Assessed PHB expression in cancer patients.
- Treated MCF-7 and MDAMB-231 breast cancer cells with MG.
- Utilized apoptosis assays (AO/PI, phosphatidylserine externalization, cell cycle, DAPI staining).
- Analyzed protein expression (cytochrome c, p53, caspase-7, survivin, Bcl-2, Bcl-xL, NF-κB).
- Measured mitochondrial membrane potential and reactive oxygen species (ROS).
- Investigated lncRNA modulation and p65 nuclear translocation.
Main Results:
- PHB alterations correlated with reduced patient survival.
- MG inhibited breast cancer cell growth, inducing apoptosis via mitochondrial pathways.
- MG suppressed pro-survival proteins and modulated NF-κB signaling and lncRNAs.
- MG treatment increased ROS generation in cancer cells.
Conclusions:
- PHB plays a significant role in breast cancer progression.
- Moringin exhibits potent anti-cancer activities by targeting multiple pathways, including apoptosis induction and NF-κB inhibition.
- MG demonstrates potential as a therapeutic agent for breast cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...

